you are here: Home News Glaxosmithkline

Glaxosmithkline

GlaxoSmithKline Standalone September 2025 Net Sales at Rs 973.63 crore, down 2.64% Y-o-Y
GlaxoSmithKline Consolidated September 2025 Net Sales at Rs 979.94 crore, down 3.05% Y-o-Y
GlaxoSmithKline Consolidated June 2025 Net Sales at Rs 805.17 crore, down 1.16% Y-o-Y
GlaxoSmithKline Standalone June 2025 Net Sales at Rs 804.83 crore, down 0.76% Y-o-Y
GlaxoSmithKline Standalone March 2025 Net Sales at Rs 966.08 crore, up 6.06% Y-o-Y
GlaxoSmithKline Consolidated March 2025 Net Sales at Rs 974.37 crore, up 4.79% Y-o-Y
GlaxoSmithKline Consolidated December 2024 Net Sales at Rs 949.42 crore, up 17.9% Y-o-Y
GlaxoSmithKline Consolidated September 2024 Net Sales at Rs 1,010.77 crore, up 5.62% Y-o-Y
GlaxoSmithKline Standalone September 2024 Net Sales at Rs 1,000.05 crore, up 4.9% Y-o-Y
GlaxoSmithKline Consolidated June 2024 Net Sales at Rs 814.65 crore, up 6.96% Y-o-Y
GlaxoSmithKline Standalone June 2024 Net Sales at Rs 811.00 crore, up 9.89% Y-o-Y
GlaxoSmithKline Consolidated March 2024 Net Sales at Rs 929.80 crore, up 18.08% Y-o-Y
GlaxoSmithKline Standalone March 2024 Net Sales at Rs 910.87 crore, up 16.46% Y-o-Y
GlaxoSmithKline Consolidated December 2023 Net Sales at Rs 805.26 crore, up 0.37% Y-o-Y
GlaxoSmithKline Standalone December 2023 Net Sales at Rs 804.98 crore, up 0.73% Y-o-Y
GlaxoSmithKline Standalone September 2023 Net Sales at Rs 953.38 crore, up 5.27% Y-o-Y
GlaxoSmithKline sues Pfizer over patents for RSV vaccine
GlaxoSmithKline Consolidated June 2023 Net Sales at Rs 761.66 crore, up 2.22% Y-o-Y
GlaxoSmithKline Standalone June 2023 Net Sales at Rs 738.02 crore, up 1.17% Y-o-Y
GlaxoSmithKline Standalone March 2023 Net Sales at Rs 782.16 crore, down 1.23% Y-o-Y
GlaxoSmithKline Consolidated March 2023 Net Sales at Rs 787.45 crore, down 2.74% Y-o-Y
GlaxoSmithKline Standalone December 2022 Net Sales at Rs 799.11 crore, down 1.1% Y-o-Y
GlaxoSmithKline Consolidated December 2022 Net Sales at Rs 802.30 crore, down 1.67% Y-o-Y
GlaxoSmithKline Standalone September 2022 Net Sales at Rs 905.61 crore, down 8.67% Y-o-Y
GlaxoSmithKline Consolidated September 2022 Net Sales at Rs 916.87 crore, down 9.21% Y-o-Y

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Glaxosmithkline

GlaxoSmithKline Standalone September 2025 Net Sales at Rs 973.63 crore, down 2.64% Y-o-Y

GlaxoSmithKline Consolidated September 2025 Net Sales at Rs 979.94 crore, down 3.05% Y-o-Y

GlaxoSmithKline Consolidated June 2025 Net Sales at Rs 805.17 crore, down 1.16% Y-o-Y

GlaxoSmithKline Standalone June 2025 Net Sales at Rs 804.83 crore, down 0.76% Y-o-Y

GlaxoSmithKline Standalone March 2025 Net Sales at Rs 966.08 crore, up 6.06% Y-o-Y

GlaxoSmithKline Consolidated March 2025 Net Sales at Rs 974.37 crore, up 4.79% Y-o-Y

GlaxoSmithKline Consolidated December 2024 Net Sales at Rs 949.42 crore, up 17.9% Y-o-Y

GlaxoSmithKline Consolidated September 2024 Net Sales at Rs 1,010.77 crore, up 5.62% Y-o-Y

GlaxoSmithKline Standalone September 2024 Net Sales at Rs 1,000.05 crore, up 4.9% Y-o-Y

GlaxoSmithKline Consolidated June 2024 Net Sales at Rs 814.65 crore, up 6.96% Y-o-Y

GlaxoSmithKline Standalone June 2024 Net Sales at Rs 811.00 crore, up 9.89% Y-o-Y

GlaxoSmithKline Consolidated March 2024 Net Sales at Rs 929.80 crore, up 18.08% Y-o-Y

GlaxoSmithKline Standalone March 2024 Net Sales at Rs 910.87 crore, up 16.46% Y-o-Y

GlaxoSmithKline Consolidated December 2023 Net Sales at Rs 805.26 crore, up 0.37% Y-o-Y

GlaxoSmithKline Standalone December 2023 Net Sales at Rs 804.98 crore, up 0.73% Y-o-Y

GlaxoSmithKline Standalone September 2023 Net Sales at Rs 953.38 crore, up 5.27% Y-o-Y

GlaxoSmithKline sues Pfizer over patents for RSV vaccine

GlaxoSmithKline Consolidated June 2023 Net Sales at Rs 761.66 crore, up 2.22% Y-o-Y

GlaxoSmithKline Standalone June 2023 Net Sales at Rs 738.02 crore, up 1.17% Y-o-Y

GlaxoSmithKline Standalone March 2023 Net Sales at Rs 782.16 crore, down 1.23% Y-o-Y

GlaxoSmithKline Consolidated March 2023 Net Sales at Rs 787.45 crore, down 2.74% Y-o-Y

GlaxoSmithKline Standalone December 2022 Net Sales at Rs 799.11 crore, down 1.1% Y-o-Y

GlaxoSmithKline Consolidated December 2022 Net Sales at Rs 802.30 crore, down 1.67% Y-o-Y

GlaxoSmithKline Standalone September 2022 Net Sales at Rs 905.61 crore, down 8.67% Y-o-Y

GlaxoSmithKline Consolidated September 2022 Net Sales at Rs 916.87 crore, down 9.21% Y-o-Y